The Global Health Body Sounds Alert Over Severe Lack of Weight-Loss Jabs
Fewer than one in 10 patients who could benefit from GLP-1 drugs such as Wegovy are able to get them, warns the global health agency as it releases its initial guidance on the therapies.
Given in excess of 1,000,000,000 people worldwide now classified as obese, it is calling for broader and more equitable access to these injectable treatments.
According to estimates, more than two billion are projected to be obese by 2030 if no action is taken.
"Our new guidance recognises that excess weight is a long-term condition that can be managed with holistic and continuous support," remarked its chief Tedros Adhanom Ghebreyesus.
Significant expense, insufficient output, and supply-chain constraints are significant obstacles to widespread access to the treatments that can aid individuals in losing significant body mass, notes the agency.
Skinny Jab Shortage
Despite the current most favorable outlook, the manufacturing of these medications could only cover approximately 100 million people – less than 10% of those who need them, according to the WHO.
The recommendation encourages governments and firms to widen availability, through strategies like patent sharing.
A patent on a key compound – the primary component of a leading brand – is set to lapse in multiple countries in 2026.
How Weight-Loss Injections Work
GLP-1 drugs imitate a body's own hormone to delay gastric emptying, reduce hunger and enhance the sense of being full so people reduce food intake.
Individuals typically see weight reduction after several weeks of starting on the weekly injections.
Studies indicates people may put most of the weight back on after a year of stopping the treatment, as their typical hunger come back.
Being carrying excess weight raises your chance for developing medical conditions, including type 2 diabetes, heart disease, stroke, and certain malignancies.
Obesity affects people in countries worldwide and was responsible for 3.7 million fatalities worldwide in 2024, per the WHO.
